In collaboration with pharmaceutical, medical device, biotechnology and medical diagnostic companies, Scripps is reinventing the nature of clinical trials. Our Advanced Clinical Trials capitalize on the latest in genetic technology.

Instead of broadly testing 10,000 people through a scatter approach, genetic knowledge is improving our aim. Utilizing individual genetic data, our highly advanced clinical trials specifically target small groups of 500 or less who share a particular gene variant.

Scripps’ Advanced Clinical Trials bring the promise of genetic discovery full circle. Genetic data is used to identify potential research opportunities, which lead to highly targeted clinical trials and a shorter time between laboratory discoveries and their application in patient care. This elegant matching of an individual’s genetic makeup with precise, gene-based medications and devices will lead to treatments that are generally safer and more effective than what is common practice today.